Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shiratori

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Gut|December 10, 1997
High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in JapanK Ogura, F Kanai, S Maeda, et al.
Bioscience, Biotechnology, and Biochemistry|March 1, 1997
The base specificities of tomato ribonuclease (RNase LE) and its Asp44 mutant enzyme expressed from yeast cellsK Ohgi, Y Shiratori, A Nakajima, et al.
Gut|February 23, 1999
Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivoM Ohashi, F Kanai, H Ueno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 4, 2000
[Percutaneous tumor ablation therapy for the advanced stage of HCC]T Teratani, S Shiina, S Obi, et al.
British Journal of Cancer|November 26, 1999
Activation of cyclin D1-related kinase in human lung adenocarcinomaK Igarashi, T Masaki, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|August 1, 2000
Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducerN Kato, H Yoshida, S K Ono-Nita, et al.
AJR. American Journal of Roentgenology|April 20, 2001
Mr cholangiography with volume rendering: receiver operating characteristic curve analysis in patients with choledocholithiasisH Kondo, M Kanematsu, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
pp60c-src activation in hepatocellular carcinoma of humans and LEC ratsT Masaki, M Okada, Y Shiratori, et al.
Gut|February 13, 2004
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis CH Yoshida, R Tateishi, Y Arakawa, et al.
Hepatology (Baltimore, Md.)|November 28, 2000
Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesionY Koike, Y Shiratori, S Sato, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Gut|December 10, 1997
High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in JapanK Ogura, F Kanai, S Maeda, et al.
Bioscience, Biotechnology, and Biochemistry|March 1, 1997
The base specificities of tomato ribonuclease (RNase LE) and its Asp44 mutant enzyme expressed from yeast cellsK Ohgi, Y Shiratori, A Nakajima, et al.
Gut|February 23, 1999
Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivoM Ohashi, F Kanai, H Ueno, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 4, 2000
[Percutaneous tumor ablation therapy for the advanced stage of HCC]T Teratani, S Shiina, S Obi, et al.
British Journal of Cancer|November 26, 1999
Activation of cyclin D1-related kinase in human lung adenocarcinomaK Igarashi, T Masaki, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|August 1, 2000
Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducerN Kato, H Yoshida, S K Ono-Nita, et al.
AJR. American Journal of Roentgenology|April 20, 2001
Mr cholangiography with volume rendering: receiver operating characteristic curve analysis in patients with choledocholithiasisH Kondo, M Kanematsu, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
pp60c-src activation in hepatocellular carcinoma of humans and LEC ratsT Masaki, M Okada, Y Shiratori, et al.
Gut|February 13, 2004
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis CH Yoshida, R Tateishi, Y Arakawa, et al.
Hepatology (Baltimore, Md.)|November 28, 2000
Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus-an analysis of 236 consecutive patients with a single lesionY Koike, Y Shiratori, S Sato, et al.
Pageof 22